Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Keratin 18 pseudogene 3 (KRT18P3) is a processed pseudogene related to the keratin 18 gene (KRT18), which encodes a type I intermediate filament protein expressed in epithelial cells. Pseudogenes like KRT18P3 resemble functional genes at the DNA sequence level but are typically non-coding and considered nonfunctional, as they lack the ability to produce a functional protein product. KRT18P3 does not have an intact open reading frame and is not implicated in any known biological pathways or diseases. It is not utilized as a drug target, diagnostic, or prognostic marker, and has no known interacting drugs or therapeutic relevance. Its presence in the genome is a result of gene duplication or retrotransposition events and it is classified solely as a pseudogene[4].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Keratin 18 pseudogene 3 (KRT18P3).